Cargando…
Current Status of Cell-Based Therapy in Patients with Critical Limb Ischemia
(1) Background: The treatment of peripheral arterial disease (PAD) is focused on improving perfusion and oxygenation in the affected limb. Standard revascularization methods include bypass surgery, endovascular interventional procedures, or hybrid revascularization. Cell-based therapy can be an alte...
Autores principales: | Jaluvka, Frantisek, Ihnat, Peter, Madaric, Juraj, Vrtkova, Adela, Janosek, Jaroslav, Prochazka, Vaclav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731417/ https://www.ncbi.nlm.nih.gov/pubmed/33256237 http://dx.doi.org/10.3390/ijms21238999 |
Ejemplares similares
-
Endovascular Repair of Thoracic Aorta Injury: 17 Years of Single-Center Experience
por: Procházka, Václav, et al.
Publicado: (2021) -
Post-Kidney Transplantation Results After Circulatory or Brain Death Without Pre-Mortem Heparin Administration
por: Roman, Jan, et al.
Publicado: (2022) -
Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia
por: Madaric, Juraj, et al.
Publicado: (2016) -
The Role of miR-126 in Critical Limb Ischemia Treatment Using Adipose-Derived Stem Cell Therapeutic Factor Concentrate and Extracellular Matrix Microparticles
por: Procházka, Václav, et al.
Publicado: (2018) -
Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells
por: Altaner, Cestmir, et al.
Publicado: (2013)